ABCB1(MDR 1) Polymorphisms and Progression-Free Survival among Women with Ovarian Cancer following Paclitaxel/Carboplatin Chemotherapy-Reference-Cited by-同舟云学术

ABCB1(MDR 1) Polymorphisms and Progression-Free Survival among Women with Ovarian Cancer following Paclitaxel/Carboplatin Chemotherapy

Published:2008-09-01 Issue:17 Volume:14 Page:5594-5601
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Johnatty Sharon E.,Beesley Jonathan,Paul Jim,Fereday Sian,Spurdle Amanda B.,Webb Penelope M.,Byth Karen,Marsh Sharon,McLeod Howard,Harnett Paul R.,Brown Robert,deFazio Anna,Chenevix-Trench Georgia,

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peroxiredoxin-1 as a molecular chaperone that regulates glutathione S-transferase P1 activity and drives mutidrug resistance in ovarian cancer cells;Biochemistry and Biophysics Reports;2024-03

2. Progress of mesoporous silica coated gold nanorods for biological imaging and cancer therapy;ChemMedChem;2023-11-22

3. Impact of ABCB1 , ABCC1 , ABCC2 , and ABCG2 variants in predicting prognosis and clinical outcomes of north Indian lung cancer patients undergoing platinum‐based doublet chemotherapy;The Journal of Gene Medicine;2022-11-14

4. Association between polymorphisms of ABCB1 and prognosis in esophageal squamous cell carcinoma patients treated with taxane;The Journal of Gene Medicine;2022-06-16

5. No Association between ABCB1 G2677T/A or C3435T Polymorphisms and Survival of Breast Cancer Patients—A 10-Year Follow-Up Study in the Polish Population;Genes;2022-04-21